4th Quarter - Report

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Firm
Client
Income
$245,484
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 3122 (119th), H.R. 5371 (119th), H.R. 4273 (119th), H.R. 6868 (119th), H.R. 3686 (119th), S. 2491 (119th), S. 2529 (119th), S. 2292 (119th), H.R. 2821 (119th), H.R. 1 (119th), S. 355 (119th)

Pharmacy PHA

H.R.4958 - GRAS Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office; Drug Enforcement Administration (DEA); SENATE

Bills named: H.R. 4958 (119th)

Consumer Issues/Safety/Products CSP

- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year.

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1219 (119th)

Manufacturing MAN

- Pharmaceutical Tariffs

LobbyistCovered position, as disclosed
JOLIE BROCHIN —
MARC SCHLOSS —
DAVID CHARLES SPANGLER —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.